Developer of a mobile application for treatment of lymphedema. The company develops a mobile application allowing patients of lymphedema to live autonomously and mitigate the effects of the disease.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Angel (individual) | 02-May-2018 | $1.99M | 00.000 | 00.000 | Completed | Startup |
4. Angel (individual) | 04-May-2017 | 00000 | 00000 | 00.000 | Completed | Startup |
3. Accelerator/Incubator | 15-Sep-2015 | 00000 | Completed | Startup | ||
2. Seed Round | 09-Sep-2015 | $401K | $401K | 00.000 | Completed | Startup |
1. Grant | Completed | Startup |
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary | 000,000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | ||
Ordinary | 000,000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | ||
Ordinary | 180,000 | $2.45 | $2.45 | 1x | $2.45 | 8.08% |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Victor Matia | Co-Founder & Chief Executive Officer | ||
Jean-Paul Belgrado | Co-Founder & Scientific advisor |
Growth Rate
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialInvestor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Start it @KBC | Accelerator/Incubator | 000 0000 | 000000 0 | ||
The Brussels Institute for Research and Innovation | Government | 000 0000 | 000000 0 |